Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

For patients with severely compromised lung function, an important treatment is supplemental oxygen. Flawed Medicare payment ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...